Companies have long lamented Europe’s fragmented capital markets, single-market adoption on pricing and clinical trials, and uneven reimbursement policies.
Source: US Top News and Analysis
Related Posts
Tuesday’s big stock stories: What’s likely to move the market in the next trading session
The S&P 500 logged a third consecutive losing session on Monday as higher oil prices…
Amazon CEO Jassy defends $200 billion AI spend: “We’re not going to be conservative”
Amazon shares have struggled so far this year as investors question the company’s aggressive AI…
Back-up care benefits at work go beyond kids, aging parents as more employers pay for pets
Companies are expanding employee benefits to cover a wide variety of caregiving needs, including back-up…